Chlorhydrate of Ropivacaine and Breast Cancer Surgery
Breast Neoplasms, Pain,Postoperative
About this trial
This is an interventional treatment trial for Breast Neoplasms focused on measuring Female, Anesthetics,local
Eligibility Criteria
Inclusion Criteria: Breast cancer patients treated by conservative surgery with axillary node dissection or treated by mastectomy with or without axillary node dissection or sentinel lymph node biopsy. ASA physical status 1, 2 or 3 With a minimum life expectancy of 2 years Written informed consent Exclusion Criteria: Any previous cancer other than breast cancer Allergies to local anesthesic and morphine Reported history of drug Pregnancy Homolateral breast surgery during the last 3 years Analgesic use pre-operatively Renal, pulmonary or liver major dysfunction Active malignant disease Unable to follow the protocol for any reason
Sites / Locations
- René Huguenin Center
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Ropivacaïne
placebo